Lakeside Holding signs $1.5M sales agreement with Sinopharm Group subsidiary
Sales Agreement Details: Hupan Pharmaceutical, a subsidiary of Lakeside Holding, has signed a $1.5M Sales Agreement with Sinopharm Holding Hubei New Special Medicine for the sale of critical medicines effective from January 1, 2025.
Partnership Context: This agreement follows a recent partnership with Sinopharm Group aimed at enhancing essential medicine storage, transportation, and logistics services.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on LSH
About LSH
About the author

Lakeside Holding files to sell 7.4M shares of common stock for holders
Lakeside Holding Stock Offering: Lakeside Holding (LSH) has filed to sell 7.4 million shares of common stock for its holders.
Recent Company Developments: The company has announced board resignations and appointments, as well as secured new distribution agreements with Kelun Pharmaceutical.

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Securities Purchase Agreement: Lakeside Holding Limited has entered into a securities purchase agreement to sell up to $4.5 million in senior secured convertible promissory notes, with the first tranche generating approximately $930,000 in gross proceeds.
Company Overview: Lakeside is a U.S.-based supply chain solution provider focused on the Asia-Pacific market, operating through its subsidiaries American Bear Logistics and Hupan Pharmaceutical, enhancing its logistics capabilities in both general and pharmaceutical sectors.






